Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Q-Pad Test System

K-Number: K231465 · 2023-12-06

ApplicantQurasense
Decision Date2023-12-06
Product CodeLCP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

Q-Pad Test System is a medical device manufactured by Qurasense. It received FDA 510(k) clearance on 2023-12-06 under approval number K231465. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Q-Pad Test System?

Q-Pad Test System is a medical device that received FDA 510(k) clearance on 2023-12-06. It is manufactured by Qurasense. The 510(k) number is K231465.

When was Q-Pad Test System approved by the FDA?

Q-Pad Test System received FDA 510(k) clearance on 2023-12-06, under approval number K231465.

What company makes Q-Pad Test System?

Q-Pad Test System is manufactured by Qurasense.

What is the FDA product code for Q-Pad Test System?

The FDA product code for Q-Pad Test System is LCP.

Related Devices (Code: LCP)

K160762Diazyme Direct HbA1c Assay (Enzymatic, On-Board Lysis), Diazyme Direct HbA1c Assay Calibrator Set, Diazyme Direct HbA1c Assay Control SetDiazyme Laboratories K142664URight Hemoglobin A1c system, FORA A1c SystemTaidoc Technology Corporation K171650Alere Afinion HbA1c and ACR on Afinion 2 analyzerAbbott Rapid Diagnostics K170147Lucica Glycated Albumin-LAsahi Kasei Pharma Corporation K163633cobas HbA1c Test, cobas b 101 systemRoche Diagnostics Operations K161533A1C EZ Glycohemoglobin Analysis SystemBiohermes Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑